Multi-Center Acute Safety Trial of TactiCath™ Contact Force Ablation Catheter, Sensor Enabled™ (TactiCath SE) for the Treatment of Drug Refractory Recurrent Symptomatic Paroxysmal Atrial Fibrillation
Phase: NA
Conditions: Paroxysmal Atrial Fibrillation
Sponsor: Abbott Medical Devices

 
Clinical Investigation Plan Cover Page 
 
 
 
This confidential document is the property of Abbott and shall not be reproduced, distributed, disclosed or used without the 
express written consent of Abbott. 
87173 CIP Posting Cover Page Ver B 
Template 
Page 1 of 1 
 
NCT Number: NCT03354663 
TactiSense IDE 
Multi-Center Acute Safety Trial of TactiCath™ Contact Force Ablation Catheter, Sensor Enabled™ 
(TactiCath SE) for the Treatment of Drug Refractory Recurrent Symptomatic Paroxysmal Atrial 
Fibrillation 
Study Document No: SJM-CIP-10216 
Version E 
Date: 06-MAR-2018 
 
 
Sponsor  
 
 
Abbott 
        
 
 
 
5050 Nathan Lane N 
      
  
 
 
Plymouth, MN 55442 
        
 
 
 
United States